Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;42(12):3829-3836.
doi: 10.1007/s10792-022-02403-5. Epub 2022 Jul 25.

Efficacy of subthreshold micropulse laser combined with ranibizumab in the treatment of diabetic macular edema

F Bıçak  1 , Ö R Kayıkçıoğlu  2 , M Altınışık  2 , S Doğruya  3 , E Kurt  2
Affiliations

Efficacy of subthreshold micropulse laser combined with ranibizumab in the treatment of diabetic macular edema

F Bıçak et al. Int Ophthalmol. 2022 Dec.

Abstract

Purpose: In this study, we aimed to evaluate and compare the visual acuity, macular volume, central macular thickness, change in number of intravitreal ranibizumab injections with micropulse laser applications after loading dose of anti-VEGF to DME patients.

Study design: Retrospective study.

Methods: This study was carried out on 97 patients (45 ranibizumab and 52 micropulse grid laser+ranibizumab) with diabetic macular edema patients who were followed in the Retina Unit. At the control visit after three loading ranibizumab injections administered once a month, micropulse grid laser was applied to one group and ranibizumab injection was continued PRN to both groups for an average of 9.27 ± 2.42 months and central macular thickness, macular volume and visual acuity were recorded.

Results: There was no significant difference between the groups in terms of gender, smoking and systemic diseases, initial central macular thickness, macular volume and visual acuity measurements (p > 0.05). Central macular thickness, macular volume and visual acuity values measured at the last follow-up of the patients were not significantly different between the groups (p > 0.05). The mean post-treatment injection requirement was 4.19 ± 1.01 for the ranibizumab with micropulse laser combination group and 5.53 ± 1.14 for the ranibizumab group (p < 0.001).

Conclusion: Micropulse laser treatment after initial loading doses reduces the need for anti-VEGF injections. There is no deleterious effect on visual acuity and retinal imagings. Therefore, while combination therapy provides an effective treatment, it can also reduce the risk of complications of intravitreal anti-VEGF injections. Studies with the participation of more patients may help in the selection of treatment methods by comparing micropulse laser combined with different injection protocols.

Keywords: Central macular thickness; Diabetic macular edema; Macular volume; Micropulse laser; Ranibizumab.

PubMed Disclaimer

References

    1. Bhagat N, Grigorian RA, Tutela A et al (2009) Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 54:1–32. https://doi.org/10.1016/j.survophthal.2008.10.001 - DOI - PubMed
    1. ETDRSr. (1985) Photocoagulation for diabetic macular edema. early treatment diabetic retinopathy study report number 1. early treatment diabetic retinopathy study research group. Arch Ophthalmol 103: 1796–806. https://doi.org/10.1001/archopht.1985.01050120030015
    1. Fong DS, Strauber SF, Aiello LP et al (2007) Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 125:469–480. https://doi.org/10.1001/archopht.125.4.469 - DOI - PubMed
    1. Massin P, Massin P, Bandello F, Garweg JG et al (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double masked, multicenter phase II study. Diabetes Care 33(11):2399–2405. https://doi.org/10.2337/dc10-0493 - DOI - PubMed - PMC
    1. Elman MJ, Aiello LP, Beck RW et al (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064–77.e35. https://doi.org/10.1016/j.ophtha.2010.02.031 - DOI - PubMed

LinkOut - more resources